Technical Analysis for ZYME - Zymeworks Inc.

Grade Last Price % Change Price Change
grade D 30.96 -1.31% -0.41
ZYME closed down 3.36 percent on Tuesday, August 4, 2020, on 43 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up
Historical ZYME trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish -1.31%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.31%
Earnings Movers Other -1.31%
Inside Day Range Contraction -1.31%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -4.62%
Crossed Above 20 DMA Bullish -4.62%
MACD Bullish Signal Line Cross Bullish -4.62%
Earnings Movers Other -4.62%
Wide Bands Range Expansion -4.62%
Up 3 Days in a Row Strength -4.62%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Zymeworks Inc is a Canada-based clinical-stage biopharmaceutical company. The Company focuses on the discovery, development and commercialization of multifunctional biotherapeutics. The Company's ZymeCAD platform is for protein modeling and structure-guided protein engineering. The Company's platforms include Azymetric Platform, AlbuCORE Platform, EFECT Platform and Zymelink Conjugation Platform + Cytotoxins. The Company's lead product candidate, ZW25, is a bispecific antibody, which is being evaluated in an adaptive Phase I clinical trial. Its ZW33 is a bi-specific antibody that delivers a cytotoxic payload to cancers cells by binding to different epitopes (bi-paratopic targeting) of the overexpressed HER2 protein. It focuses on developing a pipeline of preclinical product candidates and discovery-stage programs in immuno-oncology and other therapeutic areas. It analyzes protein characteristics to develop the scope of protein engineering to tackle biological systems.
Medicine Biopharmaceutical Medical Specialties Immunology Cancers Immune System Monoclonal Antibodies Antibody Cancer Immunotherapy Glycoproteins Sutro Biopharma Biological Systems Protein Engineering

Is ZYME a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 52.75
52 Week Low 20.33
Average Volume 450,393
200-Day Moving Average 38.07
50-Day Moving Average 34.91
20-Day Moving Average 31.60
10-Day Moving Average 30.67
Average True Range 1.72
ADX 18.2
+DI 18.61
-DI 19.46
Chandelier Exit (Long, 3 ATRs ) 34.54
Chandelier Exit (Short, 3 ATRs ) 34.15
Upper Bollinger Band 35.31
Lower Bollinger Band 27.90
Percent B (%b) 0.47
BandWidth 23.44
MACD Line -1.23
MACD Signal Line -1.45
MACD Histogram 0.2119
Fundamentals Value
Market Cap 794.9 Million
Num Shares 25.3 Million
EPS -3.52
Price-to-Earnings (P/E) Ratio -8.91
Price-to-Sales 35.32
Price-to-Book 2.18
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 33.55
Resistance 3 (R3) 33.67 33.08 33.18
Resistance 2 (R2) 33.08 32.52 33.01 33.06
Resistance 1 (R1) 32.22 32.18 31.93 32.10 32.94
Pivot Point 31.63 31.63 31.48 31.56 31.63
Support 1 (S1) 30.77 31.07 30.48 30.65 29.80
Support 2 (S2) 30.18 30.73 30.11 29.68
Support 3 (S3) 29.32 30.18 29.56
Support 4 (S4) 29.20